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Do the Obese Really Die Younger or Do Health 
Expenditures Buy Them Extra Years? 
 
A recent debate in the medical literature has arisen around the mortality effects of obesity. 
Whereas it has been argued that the obese die younger, the data that have become 
available do not immediately support this. This potentially undermines the hypothesis that 
modern life with its physical ease and cheap food would eventually make us die younger, and 
undermines the notion that economic growth comes with health warnings. We revisit this 
debate going over the mortality effects of obesity, using the US Health and Retirement Study. 
Whilst we find that obesity leads to chronic diseases that reduce length of life, we also find 
that the obese survive strokes and lung disease more often than the non-obese. A possible 
explanation is that the obese are under greater medical scrutiny, meaning that lung disease 
is more quickly diagnosed. This result holds when controlling for smoking and the long-term 
effects of obesity. 
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1. Introduction 
Until quite recently, medical authorities and medical researchers were fairly united in the 
finding that being overweight or obese was bad for us in nearly all ways imaginable. 
Obesity would causally increase the risk of type II diabetes, heart disease, the advent of 
chronic illnesses, deterioration in the arteries, etc. Via these effects, obesity would cost 
up to 13 years of life (Fontaine et al 2003). As a result, the World Health Organisation 
gives  an  official  warning  regarding  the  obesity  ‗epidemic‘  and  lists  no  less  than  30 
diseases that are causally related to obesity (World Health Organization, 2000).  
The consensus on the adverse effects of obesity has had profound implications for health 
policy and for the projections of future health costs.
1 For one, the consensus lead to 
expensive programs of trying to get people to lead more active lifestyles and have lead to 
calls to tax fast food. Also, the link between obesity and lifestyle has been used to argue 
that humanity pays a health price for economic development, even to the extent  that 
Olshansky et al. (2005) projected that the steady increase in life expectan cy during the 
last two centuries will st op due to the obesity epidemic .  Add to this that   future life 
expectancy is perhaps the most important variable that goes into the planning of the 
health and retirement system and  given that  the prevalence of obesity  seems almost 
certain to increase in the coming decades, this makes it of eminent  policy importance to 
get at the bottom of the obesity-life expectancy issue. 
 
In 2005 a chink emerged in the almost unanimous condemnation of  being  ‗heavy‘, 
though the chink mainly related to being overweight and not obesity.
2  Using data from 
the National Health and Nutrition Examination Survey  (NHANES I, II, III), which is a 
representative  cross-section  of  the  US  population ,  Flegal  et  al.  (2005)   found  that 
overweight people exhibit a  lower risk of premature death compared to people with a 
normal  Body  Mass  Index  (BMI);  the  excess  deaths  due  to  overweight  were  in  fact 
negative.  In addition, their estimate of excess deaths for obese people was substantially 
                                                 
1 For a discussion of the costs of obesity and other circumstances, see Sturm (2002). 
2  At that time, several studies documenting the relationship between BMI and mortality using non -
representative samples of the US population had been published.  See for example Calle et al. (2005), Calle 
et al.  (1999), Manson et al. (1999), and Manson (1995). Flegal et al. (2004) argues that studies estimating 
excess deaths due to obesity should use samples that are representative of the mortality experience of the 
population in the United States.    3 
lower than in previous studies (112,000 compared to 350,000 for the year 2000) though 
still positive.
3  Whilst that paper focussed almost entirely on being overweight, this paper 
will address the mortality effects of obesity in the confines of a panel setting where we 
are able to follow individuals continuously until death. Our findings differ from Flegal et 
al. (2005) in that we find no excess deaths from obesity at all.  We further expand on 
Flegal et al. (2005, 2007)  by addressing the hypothesis that the increases in medical 
expenditures in the last 30 years have been particularly beneficial to the obese. 
 
Our dataset is the US Health and Retirement Study which we use to systematically study 
whether obesity leads to shorter lives and, if not, what the probable pathways are via  
which obesity is good for ones life expectancy. This dataset is ideal because it follows the 
same individuals for up to 14 years and yet is rich in doctor-identified health measures as 
well as socio-economic measures and health expenditures.  
We start our investigation in Section 2 by seeing if there is any potential story at all, i.e. 
whether it is the case that the obese indeed live just as long as the non-obese. It turns out 
that the obese live significantly longer than the non-obese in our data, not just if we look 
at recent obesity but even if we look at obesity in the past.  
We then look at whether we can replicate the initial reasons for researchers to believe that 
obesity might reduce life expectancy because of its relation with various diseases. To this 
end we look at which diseases are correlated and longitudinally related to obesity in the 
HRS, finding indeed that the obese are more likely to suffer from various diseases such as 
diabetes, arthritis, and high blood pressure. In a sense this means our dataset contains the 
core puzzle that needs to be answered, i.e. that the obese suffer from more diseases but 
still don not seem to die younger. 
 
In consecutive subsections we then address the main concerns that medical scholars have 
expressed as to why one would fail to pick up a mortality increasing effect of obesity. 
                                                 
3 The popular media quickly picked up the results from this article to call into question the detrimental 
effects of obesity. See, for example Kingsland (2005) and Kolata (2007). After the publication of this 
article a huge debate regarding Flegal‘s et al. finding emerged in the medical profession.  See for example 
Kolata  (2005),  Couzin  (2005),  and  Harvard  School  of  Public  health  (2005).  Flegal  et  al.  (2007)  then 
expanded  their  analysis  to  the  relationship  between  BMI  and  cause-specific  mortality,  finding  that 
overweight people were less likely to die from non-cancer and non-Cardio Vascular Disease (CVD) but not 
reporting any specific benefits of obesity.   4 
This includes the hypothesis that there are confounding aspects like smoking (smoking 
makes you thin!) that, when not adequately dealt with, would lead to a spurious positive 
relation between obesity and length of life (Calle et al. 1999, Manson et al. 1995); and it 
includes the hypothesis that there is a reverse causality problem in that those close to 
death lose weight rapidly, making it hard to ascertain the independent effect of obesity.
4 
Whilst examining the reasons why the raw relation might be biased, we  simultaneously 
address possible explanations for why the raw relation might simply be a reflection of 
mortality benefits of obesity. To this end we examine three important possibilit ies. The 
first is that the obese are less likely to become smokers because, in a sense, they already 
have an addiction. The second is that it might be the case that obesity makes one more 
likely to survive particular diseases because of the greater mass of fuel stored allowing a 
patient to survive thinning for longer.  The final one is that the greater medical attention 
going to the obese has meant that particular health problems are diagnosed earlier and are 
thus more effectively treated for the obese than the non-obese.
5 
The main contribution of this paper is  that it is the first to address the most prevalent 
hypotheses regarding the mortality effects of obesity for a single dataset , simultaneously 
adding the importance of prevention and medical expenses to the possible explanations.  
 
The outline of this paper is as follows. The next section introduces our dataset and giv es 
some very basic  sample statistics to ascertain that our longitudinal dataset in broad 
outlines gives similar cross -sectional results as  those used hitherto in this literature. 
Section 3 then systematically addresses all the various possibilities mentioned in the 
literature for why obesity might reduce length-of life, and whether these hold up to closer 
scrutiny. There, we also extend on the previous literature by looking at whether we can 
identify any positive effects of obesity, such as a reduced probability of becoming a 
smoker and a smaller chance of dying from certain chronic diseases. Section 4 concludes. 
 
                                                 
4 Lawlor et al., 2006 studies these issues using ―community-based‖ data from Scotland. 
5 There is a large literature on obesity-relevant medical advances in the last 30 years, including the 
increased use of carotid endarterectomy procedures or heart transplants (Pamuk et al. 1998; American 
Heart Foundation, 2006; Livingston, 2007; National Center for Health Statistics, 2007), the increases in the 
use of blood thinners (Mehta et al. 2006), and the increased use of bariatric surgery (Buchwald et al., 2004).   5 
2. The Health and Retirement Study (HRS) 
 
To analyse obesity mortality we use data from the first eight waves of the Health and 
Retirement  Study  (HRS).  The  HRS  is  a  longitudinal  study  with  a  core  sample 
representative of the US population over the age of 50 that are interviewed once every 
two years, and includes a rich set of health characteristics, notably BMI at each interview, 
smoking, and information on doctor-diagnosed long-term health conditions.
6  The survey 
also collects detailed information on a broad spectrum of socio-economic characteristics, 
such as income, wealth, job information, and retirement.  Our sample consists of all 
individuals ever included in the sample who have complete information on the variables 
of interest. The sample   includes many younger individuals who ar e partnered to the 
individuals in the core sample.   
 
It is important to point out that it hardly matters to a study of mortality that the young are 
under-represented, simply  because  t he  odds  of  dying  before  50  of  a  health -related 
problem are minimal (discounting child deaths). In 2005, only 4 per 1000 individuals 
between the age of 1 and 45 died, and only 8.5 per 1000 between 1 and 55  did. Of these 
deaths before 45, about half is due to accidents, homicide or suicide. Hence only about 3 
in 1000 people die due to non-birth health-related deaths before the age of 51  (Kung, 
2005). More worrying than lacking many youngsters in our data is that we do not have 
information about the height and weight of individuals when they were young, and hence 
are not able to ascertain the effect of childhood obesity on old-age mortality. 
 
The HRS started in 1992 with a  single cohort born between 1931 and 1941.   After this 
year, four more cohorts have been included: 1) born before 1924  (from the Study of 
Assets and Health Dynamics Among the Oldest Old, 1993); 2) born between 1924 and 
1930 (added in 1998); 3) born between 1942 and 1947 (added in 1998); and 4) those born 
between 1958 and 1953 (added in 2004). Our sample, therefore, covers the period 1992-
2006 and contains 30,405 people in total. 
 
                                                 
6 For more information about the HRS visit: http://hrsonline.isr.umich.edu/.   6 
The number of deaths starting from wave 2 is 229, 1080, 1318, 1392, 1530, 1275, and 
1370 in wave 8.  In total there are 8154 deaths, approximately 27 per cent of the total 
number of people ever included in the sample, which is certainly high enough to do 
meaningful analyses on.  
 
The first thing we investigate is how the probability of dying differs for obese and non-
obese people across the years.  Table 1 shows the probability of dying in the current 
period conditional upon being obese/non-obese two years before death (t-1), four years 
before  death  (t-2),  and  so  forth.    Following  standard  practice  in  the  literature  an 
individual is considered obese if his Body Mass Index (BMI) exceeds 30.
7 The fourth 
column in the table reports the difference in the probability of dying between the obese 
and the non-obese  and, in column 5, it shows the  p-value for the hypothesis  of  this 
difference being equal to zero. The figures show that those considered obese exhibit a 
lower probability of dying at time t.  People who were non-obese two years before dying 
(t-1), for example, had a 5.81 percent probability of dying compared to a 3.06 per cent 
probability for the obese, making the obese 2.6 percentage points less likely to die next 
period than the non-obese. If we go back further in time, we observe the same direction 
of correlation though the magnitudes become smaller: those who were obese 12 years 
previously still show a 0.5 percentage point lower probability of dying 12 years later than 
the non-obese. 
 
[Table 1 here] 
 
The raw relation in our data is thus indeed that the obese tend to live longer than the non-
obese. The next question is whether they nevertheless suffer from more health conditions. 
Table 2 shows for the obese and non-obese the probably of having experienced various 
health problems since the last interview, i.e. in the 2 years preceding the interview.  From 
the table we see that the obese are 18 percentage points more likely to have experienced 
high  blood  pressure  in  the  current  period;  14  percentage  points  more  likely  to  have 
experienced diabetes; 1.2 percentage points more likely to have experienced chronic lung 
                                                 
7 The BMI is calculated as the ratio between an individual‘s weight in kilograms and their height in meters 
squared.   7 
disease; 1.9 percentage points more likely to have experienced a heart attack (and related 
diseases); 3.7 percentage points more likely to have experienced emotional/psychiatric 
problems; and 13 percentage points more likely to have experienced arthritis. The obese, 
nevertheless, are 1.2 percentage points less likely to have developed cancer and 0.6 less 
likely to have had a stroke.  If we would simply add up the believed mortality effects of 
each of these diseases for the obese and the non-obese, an obese individual would live 2.4 
less years than a non-obese individual.
8 
 
[Table 2 here] 
 
 
The conclusion from the simple statistics in Tables 1 and 2 is that in our dataset too, there 
is a puzzle: the obese do not seem to die younger (indeed they are less likely to die) even 
though they identifiably are more likely to suffer from several sever e diseases. Since 
these data are distinct from those used previously and is designed to be representative of 
the population over 51, these simple statistics severely weaken the potential criticism that 
the health benefits from being heavy were only to be found in the dataset used by  Flegal 
et al. (2005). 
 
3. Analyses 
We address two main critiques that one can have against the raw findings above, both in 
the  direction  of  arguing  the  presence  of  reverse  causality.  The  first  is  that  smoking 
reduces  BMI  and  thus  makes  a  person  less  likely  to  be  obese  whilst  smoking  is 
undoubtedly detrimental to length of life. Not accounting for smoking then could lead to 
the effects of obesity being more about ‗not being a smoker‘ rather than being obese per 
se.  The  second  potential  critique  is  that  death  may  be  associated  with  thinning 
beforehand, again causing reverse causality problems. 
 
  Smoking and other confounding pathways 
                                                 
8 Calculated as the product between the difference in probability for obese and non-obese people in Table 2 
and the average years of life lost per person due to (i) diabetes, (ii) chronic lung disease and (iii) heart 
attack, using the estimates of Ries et al. (2007) for their mortality effect. 
   8 
It  is  important  to  note  that  the  lack  of  ‗controlling‘  for  confounding  variables  like 
smoking does not immediately lead to an obvious bias: it is indeed the case that the obese 
smoke less than the non-obese (see Table 2; Manson et al., 2005; Calle et al. 1999) and 
its true that the smokers die earlier (e.g. Sloan et al. 2004 and the references therein), but 
that does not necessarily bias anything in any particular direction unless one knows the 
direction of causality (for an early discussion, see Arday et al. 1995). The bias in the 
direction  of  finding  an  inflated  positive  effect  of  obesity  on  life  expectation  due  to 
smoking only holds if smoking causally leads to less weight.  If it is alternatively the case 
that obesity is a ‗different addiction‘ to smoking and that it is on the aggregate true that 
being obese ‗protects one‘ against becoming a smoker in the first place, then one simply 
has found a causal pathway via which obesity leads to higher life expectancy. It needs an 
empirical analysis to see how strong these conflicting possibilities are.  
We thus examine three distinct aspects of the possible importance of smoking and other 
confounders: 1) how much smoking explains; 2) whether smoking leads to lower obesity 
and whether higher obesity leads to a lower probability of starting to smoke; and 3) how 
robust is the relationship to the inclusion of a variety of other individual characteristics 
such as initial wealth. 
 
We begin by investigating the role of smoking in the relationship between mortality and 
obesity. Table 3a presents Probit estimates where the dependent variable is death before 
the start  of the interview, i.e. death  in  the last  two  years. The variables included by 
necessity  relate  to  circumstances  in  previous  periods,  where  we  are  particularly 
concerned with the effects of obesity after adding smoking related variables. The key 
variable we are interested in is the coefficient on the lag of the obesity variables because 
that one denotes what the effect is of changing obesity from 0 to 1 in all previous periods. 
The other obesity variables are changes in obesity and thus are not related to the long-run 
effect of obesity (when all changes become 0) but to short-run effects.  
Models 1 to 4 in the table include obesity and age.  Even after controlling for age, we 
observe a negative coefficient on the obesity variables; the coefficients, however, are 
only statistically significant for obesity two and four years ago.  By including all the 
obesity history variables, we can estimate the long-run impact of being obese (Model 4) 
which we still find to be negative but insignificant (an effect of -0.039). The coefficients   9 
on the changes indicate that there is a health benefit from becoming obese, which seems 
quite likely due to reverse causality. Just as a robustness check, we re-run our Probit 
model replacing the obesity dummy variables by the actual BMI value. The advantage of 
this approach is that it uses all the variation in the BMI measure.  The BMI model in the 
table shows qualitative similar results to the model with obesity dummy variables.  The 
long-run effect of BMI (the coefficient on the last included lag) is again negative, and this 
time statistically significant, but small. What this table shows is that controlling for age or 
the history of obesity does not take away the finding that there is no life expectancy 
reduction from obesity. 
 
[Table 3a here] 
 
We now ask what happens to the relationship between obesity and mortality when we add 
smoking histories.  Table 3b shows estimates similar to the ones in Table 3a but includes 
individuals‘ smoking histories.  First of all, smoking increases the probability of dying 
next  period  no  matter  when  the  smoking  was  done.  All  coefficients  on  the  smoking 
variables are strongly statistically significant (Models 1 to 5).  
 
By comparing the coefficients on obesity in Tables 3a and 3b (Models 1 to 3) we can also 
see that including smoking reduces the effect of obesity on mortality in such a way that 
only being obese in the period immediately before dying still has a negative effect on the 
probability of dying.  In the extended model 4, the long-run effect of being obese in the 
past becomes positive but very small (0.004) and statistically insignificant. When using 
BMI instead of obesity, the relation again becomes negative, though insignificant.  
Hence  adding  smoking  to  the  regression  does  weaken  the  initial  finding  that  obesity 
increases  length  of  life  but  does  not  make  enough  difference  to  get  the  finding  that 
obesity reduces length of life. 
 
[Table 3b here] 
 
 
Then there is the issue of direction of causality. We now exploit the longitudinal aspect of 
our data where we try to explain the current smoking and obesity situation by means of   10 
the situation in the previous period, attempting to see whether smoking reduces the odds 
of being obese or whether the reverse might also be true. Table 4 shows several models 
for the effect of smoking on obesity (first three columns) and for the effect of obesity on 
smoking behaviour.  
 
We first discuss the relationship between obesity and smoking. We run two types of 
models: one where the dependent variable, obesity, is dichotomous (Probit model) and a 
GLS model where instead of obesity we use individuals‘ BMI. In both models we include 
lags of the dependent variable and control for age.  In both these models, we find that the 
impact  of  long-term  smoking,  which  is  given  by  the  sum  of  the  coefficients  of  the 
individual smoking variables, is negatively and statistically associated with being obese 
or BMI.  In particular we find that long-term smoking reduces the chance of becoming 
obese by only 1.1 percent. From the BMI model, we can also see that long-term smoking 
reduces BMI significantly but only by 0.13.  In addition to these two models, we also run 
a GLS model of the change in BMI on current smoking and smoking in the last period.  
We find in this case, however, no association between smoking and change in BMI.
9   
 
Columns 3 to 6 in Table 4 report Probit estimates for current smoking. The first model 
includes obesity history (as reflected by obese dummy variables) and  smoking history.  
The second model uses BMI instead of obesity dummy variables.  Both models suggest a 
negative relationship between long-term obesity and smoking behaviour, although in both 
cases  the long-run effects are not statistically significant at standard  levels.  The last 
model we estimate is a  Probit model for smoking using as regressor s only short-term 
smoking  and  short-term  BMI.  In  this  case  we  do  find  a  statistically  significant 
relationship between  BMI  today and  smoking two years later  (coefficient =  -0.010,  
z=6.23).  Translated to marginal effects, this implies that having a 1 point higher BMI 
today reduces the probability of being a smoker  the next period by approximately 2.1 
percent. 
Whilst the results above suggest that obesity might well indeed lead to a reduced 
probability of smoking, we do   not put too much weight on th at possibility, mainly 
                                                 
9 Flegal (2007) also looks at the relationship between changes in smoking and changes in obesity and finds 
no significative correlation.   11 
because we do not have truly ‗independent‘ random shocks to smoking and obesity via 
which to tease out causality convincingly. It is however hard to imagine data that would 
have true random variation in obesity over time: no random event that we know of can 




Finally, as Appendix Table A1 shows, the relationships above are robust to the inclusion 
of a large variety of individual factors, such as initial levels of income, wealth, education, 
ethnicity and gender. We may mention that the results are also robust to more flexible 
age-specifications (available on request). 
 
  Thinning before death and obesity 
Another important potential critique of the raw finding that the obese live longer is that 
imminent death causes people who were obese to become thin.
10  Before examining this 
empirically, it is handy to reflect on the circumstances in which this would actually lead 
to the ‗reverse bias‘ of death causing thinness rather than the other way around. The 
circumstances in which obese people would lose weight before death but where their 
obesity  does  not  prevent  earlier  death  are  very  peculiar  indeed  because  they  would 
require that those who did not have excess weight to lose but who did suffer from the 
same disease are in no way more likely to die than those that do have excess weight. 
Since the body dies if it runs out of all fuel, the ‗reverse causality story‘ can only be true 
if there is some kind of ‗plateau weight‘ at which the thinning stops and to which all 
individuals with a disease are moving. This is certainly not intuitively plausible. It is 
perhaps more plausible to think that there is no such plateau and that death becomes ever 
more probable as the body runs out of fuel, i.e. the thinner a person becomes. In that case, 
there is in fact a health benefit of obesity: obesity is then merely stored fuel useful for 
surviving a little longer. 
                                                 
10 This is the argument behind the studies by Manson et al. (1995) and Calle et al (1999). They argue that if 
obese people with a history of disease are not excluded from the baseline sample that would create a 
misleading correlation between BMI and mortality.   12 
As an initial ocular test of whether death is associated with thinning at all, Figure 1 shows 
the development of BMI by age for all those in the sample and for those known to die 
before they are 80. We effectively see that thinning takes place for both groups in equal 
measure after the age of 65, though between 50 and 65 there does appear to be a greater 
degree  of  thinning  for  those  who  are  known  to  die  before  their  80
th.  Since  the  vast 
majority of deaths occur after 65, Figure 1 already limits the degree to which one can say 
with confidence that death is associated with thinning to a greater degree than age is. 
However, the movement of BMI by age in Figure 1 is partially driven by what happens to 
individuals over time and partially by the fact that the individuals at the higher ages are 
different individuals to those at the lower ages, reducing the degree to which we can learn 
anything with confidence from Figure 1. 
Figure 2 shows average BMIs for four groups of individuals and four periods before their 
death.  To construct Figure 1 we keep only individuals who die and we follow them 
backwards in time.  Then we classify as obese those who had a BMI higher than 30 at the 
first point in time in which they were observed in the data. We classify as ill those people 
who four periods before they died reported having one of the eight diseases for which 
there is information in the data. Figure 2 then shows the average BMI for four groups of 
people who die in period t by disease: 1) all obese (ill and non-ill); 2) obese and ill; 3) All 
non-obese; and 4) ill and non-obese.  
Figure 2 shows that, effectively, all groups thin more or less at the same rate  before 
death: the ill, the non-ill, the obese, and the non-obese all see their weight reduce closer 
to death. Importantly, we do not observe a strong ‗plateau effect‘, i.e. there does not 
appear to be some critically low weight at which patients stop losing weight before they 
die. This suggests that there has to be a continued benefit of having extra weight to lose, 
though, again, Figure 2 is only a loose ocular test.  
 
[Figure 1 and Figure 2] 
 
To go beyond these somewhat inconclusive ocular tests, we look at whether the obese are 
more or less likely to survive particular diseases by combining all the information into 
Probit models of mortality. This time we include the medical history of diseases as well 
as interaction terms between obesity and these medical diseases. If obesity would lead to   13 
the ability to survive certain diseases better, this should show up as a negative sum of 
these interaction effects for certain diseases. By including the medical history we include 
the reverse-causality possibility that disease and thinning are causally related. 
Table 5 presents several specifications for mortality, controlling for age, obesity in the 
past,  chronic  diseases  and  smoking  history.    As  suggested  by  the  model  with  no 
interactions,  long-term  obese  people  tend  to  have  a  lower  probability  of  dying  next 
period, even after controlling for age, smoking, and their eight-year history of chronic 
diseases.    As  calculated  by  adding  the  time-coefficients  for  the  same  disease  in  this 
specification (not shown in table), people who suffer from chronic diseases in the long-
term are more likely to die next period, except, interestingly enough, for those with high 
blood pressure and arthritis. 
 
The models in Table 5 with interactions between obesity and each of the eight chronic 
diseases allows the test of the hypothesis we are interested in: whether the obese are more 
likely to die from certain chronic disease than the non-obese. In the bottom panel of the 
table we report the sum of the coefficients on the interactions terms by disease.  Results 
indicate  that  obese  people  who  have  a  long  history  of  diseases  such  as  high  blood 
pressure, diabetes, cancer, and psychiatric problems are just as likely to die next period as 
comparable non-obese people. We find that obese people with a history of lung disease 
are  less  likely  to  die  (the  same  is  true  for  strokes  but  the  coefficient  is  statistically 
insignificant  once  we  include  four  lags  of  the  regressors).    The  long-term  effect  of 
suffering from heart disease is also sizeable and statistically significant in two of the 
specifications.  The obese with heart conditions are, however, more likely to die next 
period  than  non-obese  comparable  individuals.
11  Summarising,  obesity  appears  to 
aggravate heart conditions, but reduces the danger coming from lung disease and maybe 
strokes as well.  Together, the results in Figure  2 and Table 5 show that many chronic 
diseases are indeed related to a thinning of the obese, but that it is also the case that 
obesity means one lasts longer in some conditions though not in others. 
 
                                                 
11 As an aside, long-term smoking is now insignificantly related to the probability of dying next period; 
however, this is not surprising since we are controlling for many of the potentials mechanisms through 
which smoking affects mortality.    14 
[Table 5 here] 
 
    Does money buy health benefits for the obese? 
A  final  important  hypothesis  we  wish  to  examine  is  whether  increased  health 
expenditures  have lead  to  particular health improvements  for the obese. To this  end, 
Figure 3 shows the relation between the increased real medical expenditure on the obese 
versus the non-obese and the marginal mortality effect of obesity over time. The medical 
expenditure line is calculated as the age-adjusted mean additional expenses on the obese, 
whilst the marginal mortality effect of obesity is calculated by running a mortality Probit 
for each period including age and obesity. 
Figure 3 shows what one would intuitively expect: real expenditures on the obese versus 
the non-obese have risen markedly since the early 1990s from a low of 778 dollars per 
year per obese to 2253 dollars in 2002, almost a tripling of the difference. At the same 
time, the marginal effect of obesity on mortality has improved, with the obese being 0.2 
percent more likely to die in 1992 and 0.69 percent less likely to die in 2004. From 
studies of the 1970 and 1980s it is furthermore quite likely that the mortality effect of 
obesity before 1992 was even higher (Calle et al. 2005; Calle et al.  1999; Manson et al. 
1999; and Manson 1995). The statistical relation between the two lines in Figure 3 is 
negative and significant at the 1 percent level, though this does not prove causality. 
What could be the causal pathways consistent with our previous findings that could have 
lead to a positive relation between health expenditures on the obese and an emerging 
mortality  benefit  of  obesity?  The  literature  and  the  above  findings  support  two 
possibilities:  a  reduction  in  the  medical  severity  of  obesity-related  diseases  and 
prevention effects. 
 
  Reductions of the severity of obesity-related diseases 
The diseases the obese suffer from more have become less lethal than in previous decades 
before  due  to  improved  medication.  This  includes  bypass  operations,  carotid 
endarterectomy  procedures,  and  heart  transplants  which  are  expensive  and  have  all 
become more common than in the past (Pamuk et al. 1998; American Heart Foundation, 
2006; Livingston, 2007; National Center for Health Statistics, 2007). It also includes a 
massive increase in the use of blood thinners like Statins, particularly amongst the obese,   15 
which greatly reduce the chances of dying from blood artery and related problems (Mehta 
et al. 2006). These mortality risks of cardiovascular diseases, strokes, and diabetes have 
hence indeed been reported to go down: Gregg et al. (2005) find that the risks from 
cardiovascular  diseases  have  gone  down  over  time.  The  decrease  has  been  quite 
spectacular: Reis et al. (2007) report a dramatic decrease in the death rate from heart 
disease for people over 65 since the early 1970s. Whilst in 1975 the death rate from heart 
disease was approximately 2,450 per 100,000, this rate was 1,400 in 2005.
12 Finally, 
Buchwald et al. (2004) shows that bariatric surgery, which has become more common, 
has substantially improved the health of morbidly obese people. Diabetes, for example, 
was complete resolved in almost 77 percent of the patients who underwent the surgery. 
 
  Prevention effects of more medical attention 
A secondary effect of the medicalization of obesity is that it has inadvertently protected 
the obese from selected diseases. Again, the widespread use of blood thinners such as 
Statins will have protected the obese from strokes which, as we can see from Table 2, the 
obese have less and, as we can see from Table 5, they die of less often. It furthermore 
seems  likely  that  regular  medical  check-ups  might  well  also  have  lead  to  the  earlier 
discovery of chronic lung disease such that it can still be effectively treated. This is 
consistent with the finding of Table 2 that the obese have a higher rate of having been 
diagnosed with chronic lung disease but why they are significantly less likely to die of it, 
as witnessed by Table 5. Both these causal mechanisms are in line with Figure 3 and 
suggest that money matters more than previously thought to matter in terms of health 
benefits (see Jones 2007 or Frijters et al. 2005). 
 
But how much does it cost and who should pay?  
What have been the costs of the health benefits arising from the medicalization of obesity 
and who pays? If we combine the prevalence of obesity in groups above age 40 in our 
sample with the population structure of the US in July 2007,
 13 then it turns out there are 
approximately 34,650,000 people older than age 40 who are considered obese.  Using our 
                                                 
12 Zizza et al (2004) finds that the obese have longer lengths of hospital stays. 
13 The percentage of obese people in the HRS data is 29 percent for those aged 40-50, 28 percent for those 
50-60, 27 percent for those 60-70, and 19 percent for those 70-80, and 11 percent for people 80 years old 
and over.     16 
estimate of extra expenditure for the obese (on average US$1,930 for the ten-year period 
1992-2002), obese people cost around 66.7 billion dollars per year in health expenditure 
in 2002 dollars, which is somewhat of an underestimate if we consider that this figure 
neglects  the obese who are  younger than 40.  It  turns out  that this  back-the-envelope 
estimate is close to the 52.4 billion figure found by Finkelstein et al. (2003) who use data 
from the National Health Interview Survey and National Health Accounts which is richer 
in medical expenditure information than our data. If we then assume that the costs per 
obese individual increase linearly in the next 10 years as they have in the last 10 years, 
and if we assume the total number of obese people remains unchanged, the costs would 
reach 86.6 billion in 2002 dollars in the next 10 years, or around 1 percent of GDP.  This 
estimate is conservative since it ignores the health costs of the overweight. 
 
Who pays this bill? Finkelstein et al. (2003) point out that half of the health cost of 
obesity is paid by Medicare and Medicaid, 35 percent by Private insurers (who are not 
allowed to differentiate fees on the basis of obesity), and 15 percent is out-of-pocket.  
This constitutes a large externality on the public purse and even on other users of private 
insurance.  From a classic economic point of view, considering obesity as the outcome of 
individual  choices,  the  textbook  economic  reaction  to  such  a  large  externality  is  to 
transfer the costs to those generating the externality.  
 
There are three potential ways in which the health bill that is currently borne by the 
whole community can be laid at the door of the obese. The first is a Pigovian ‗obesity 
tax‘ of around 2000 dollars per obese individual. The disadvantage of such a tax is that 
one  would  have  to  continuously  update  its  level  and  would  require  fairly  invasive 
monitoring. The second is to have transferable ‗obesity rights‘ bought under an auctioned 
licensing system. Though such auctioned property rights might be optimal in the case of a 
few polluters, it has to be doubted whether it could work effectively if about 40 million 
individuals were involved. The final and probably easiest way to transfer the externality 
onto the obese themselves is to let both Private and Public health insurers differentiate 
their  fees  and  the  access  to  various  medical  procedures  by  obesity.  These  textbook 
economic reactions to the externality created by the obese are welfare-superior to a fast-  17 
food  tax,  which  penalizes  not  only  the  obese  but  also  the  non-obese  and  which  can 
furthermore be expected to lead to costly monitoring and label-fudging.  
 
 
4. Conclusion: a resolution of the puzzle? 
 
In this paper we started out with the paradox that the obese suffer from more diseases and 
yet  die  later  than  the  non-obese.  Using  the  HRS  which  follows  roughly  30,000 
individuals for up to 14 years in the period 1992-2006, this paradox was shown to be 
robust to the inclusion of smoking, socio-economic variables, medical history, long-run 
effects of obesity, and the thinning that takes place over time.  
  
The overall story that emerged is that obesity has ceased being a killer for three distinct 
reasons.  For one,  there is  overwhelming literature evidence that  the diseases  that the 
obese used to die of are simply less threatening than they used to be. Medical treatments 
like bypasses and blood thinners have effectively reduced the mortality risks associated 
with  obesity.  Secondly,  within  our  dataset  obesity  seems  to  protect  one  against  the 
likelihood of taking up smoking to the tune of being 2.1 percent less likely to be a smoker 
this period if one was obese the last period. Lastly, obese individuals seem to be able to 
survive  strokes  and  chronic  lung  diseases  more  readily  than  the  non-obese,  probably 
because they already receive medication preventing strokes and due to the more regular 
check-ups allowing early detection of chronic lung disease. This points to an important 
additional  avenue  for  health  spending  to  have  improved  the  life  expectancy  of 
Americans. 
 
All in all, our findings mean that we should not expect the obesity epidemic to seriously 
reduce life expectancies and that there is no clear negative mortality effect  from our 
modern way of life via the increase in obesity. None of this is to say that obesity is a 
desirable condition because the obese still have much higher health costs and notably 
suffer from a variety of ailments and discomforts that are costly to combat. Indeed, the 
fact that they live longer merely increases the costs of obesity! Nevertheless, it appears 
that obesity is not as dangerous as once thought and that the closer medical scrutiny   18 
enjoyed by the obese is having unexpected benefits. The other side of this coin is that the 
health costs of obesity are currently around 70 billion a year, of which nearly 85% is 
borne  by  the  community  rather  than  by  the  obese  themselves.  The  logical  economic 
reaction to this is to tax the obese for generating the externality (around 2000 dollars per 
obese per year), preferably in the form of allowing for fee differentiation on the basis of 
obesity.   19 
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Health condition Non-obese Obese
Difference in probability 
(Obese - non-obese) p-value
Person-year 
observations
1. High blood pressure or hypertension .4394 .6186 .1792 .0000 139885     
2. Diabetes or high blood sugar .1161 .2578 .1417 .0000 144075     
3. Cancer or a malignant tumor of any kind (except 
skin cancer)
.1138 .1021 -.0117 .0000 144965     
4. Chronic lung disease such as chronic bronchitis 
or emphysema (except asthma)
.0878 .1000 .0122 .0000 144054     
5. Heart attack, coronary heart disease, angina, 
congestive heart failure, or other
.2131 .2323 .0192 .0000 144366     
6. Stroke or transient ischemic attack (TIA) .0621 .0554 -.0067 .0000 144424     
7. Emotional, nervous, or psychiatric problems .1310 .1683 .0374 .0000 143126     
8. Arthritis or rheumatism .4812 .6104 .1292 .0000 139908     
9. Smoking .2001 .1418 -.0583 .0000 130942     





Table 1: Probability of Dying at Time t Given Obesity in Previous Periods 
Period  Non-obese  Obese 
Difference in probability 
(Obese - non-obese)  p-value 
Person-year 
observations 
t-1  .0581  .0306  -.0275  .0000  145993     
t-2  .0594  .0379  -.0215  .0000  119733     
t-3  .0585  .0410  -.0175  .0000  94243     
t-4  .0557  .0419  -.0138  .0000  72968     
t-5  .0490  .0397  -.0093  .0000  53085     
t-6  .0406  .0349  -.0057  .0194  34611     
 
Source: Authors calculations based on RAND-HRS Version H.   
 
 
Table 2:  The Probability of Having Various other Health 
Problems for the Obese and the Non-Obese 
Source: Authors calculations based on RAND-HRS Version H.   
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Table 3a:  Probability of Dying at Time t given Obesity in Previous Periods  
Notes:  
The specification for Models 1 to 3 is        t i j t i j it X Obese Death , , 1 Pr       for j=1,2,3 . In Model 4, we estimate 
       t i t i j j t i j it X Obese Obese Death , 5 , 5
4
1 ,   1 Pr           . 
(a) The model is:         t i t i j j t i j it X BMI BMI Death , 5 , 5
4
1 ,   1 Pr            
Source: Authors calculations based on RAND-HRS Version H. Absolute value of Z-statistics in parentheses. 
 








Change obesity (t-2 to t-1) .258 .075
(5.58) (15.49)
Change obesity (t-3 to t-2) .242 .074
(4.48) (12.37)
Change obesity (t-4 to t-3) .228 .059
(4.04) (9.29)
Change obesity (t-5 to t-4) .178 .050
(3.37) (8.33)
Obese t-5 -.039 -.008
(1.23) (3.39)
Age .042 .044 .044 .040 .036
(73.51) (67.21) (57.98) (36.42) (31.46)
Constant -4.568 -4.718 -4.744 -4.598 -4.105
(106.55) (95.63) (82.58) (54.25) (34.90)
Person-year obs. 145,991 113,224 87,181 43,311 43,311
Individuals 30,284 27,284 22,148 16,079 16,079
Number of deaths 7,538 6,179 4,813 2,014 2,014  24 
Table 3b:  Probability of Dying at Time t given Obesity and smoking Histories  








Change obesity (t-2 to t-1) .275 .076
(5.82) (15.48)
Change obesity (t-3 to t-2) .240 .073
(4.34) (12.00)
Change obesity (t-4 to t-3) .217 .059
(3.74) (9.01)
Change obesity (t-5 to t-4) .153 .048
(2.84) (7.86)








Change smoking (t-2 to t-1) .146 .184
(2.43) (3.03)
Change smoking (t-3 to t-2) .142 .210
(2.15) (3.13)
Change smoking (t-4 to t-3) -.026 .043
(.38) (.63)
Change smoking (t-5 to t-4) -.168 -.106
(2.57) (1.58)
Smoking t-5 .388 .353
(11.01) (9.84)
Age .045 .048 .048 .045 .041
(74.74) (69.06) (60.03) (37.76) (32.81)
Constant -4.824 -5.055 -5.132 -5.033 -4.634
(105.14) (95.12) (82.62) (53.75) (35.85)
Person-year obs. 145,409 112,806 86,891 42,358 42,358
Individuals 30,279 27,280 22,147 15,922 15,922
Number of deaths 7,508 6,160 4,794 1,967 1,967  
Notes: The specification for Models 1 to 3 is         t i j t i j j t i j it X Smoke Obese Death , , , 1 Pr         for j=1,2,3. In 




1 ,   1 Pr            . 
(a) The model is           t i t i j j t i j t i j j t i j it X Smoke Smoke BMI BMI Death , 5 , 5
4
1 , 5 , 5
4
1 ,   1 Pr                   
Source: Authors calculations based on RAND-HRS Version H. Absolute value of Z-statistics in 





BMI       
(OLS)
BMI         
(OLS)
Using obese as 
regressor 
(c)
Using BMI as 
regressor 
(c)
Using BMI as 
regressor 
(d)
Obese t-1 1.491 -.025
(56.16) (.43)
Obese t-2 .759 -.085
(25.04) (1.31)
Obese t-3 .479 -.055
(14.95) (.84)
Obese t-4 .479 .118
(15.99) (1.99)
BMI t-1 .619 -.021 -.010
(110.12) (2.91) (6.23)
BMI t-2 .194 -.010
(28.77) (1.14)
BMI t-3 .092 .006
(13.30) (.62)
BMI t-4 .069 .021
(11.81) (2.68)
Smoking t-1 -.295 -.380 -.423 1.758 1.741 3.090
(5.64) (6.26) (11.96) (45.50) (44.87) (204.16)
Smoking t-2 .066 .097 .407 .828 .823
(1.12) (1.43) (11.95) (18.10) (17.93)
Smoking t-3 .120 .020 .525 .531
(2.03) (.30) (10.59) (10.69)
Smoking t-4 .029 .131 .553 .560
(.57) (2.33) (11.81) (11.92)
Age -.020 -.036 -.009 -.010
(17.21) (30.47) (5.06) (5.69)
Constant -.371 3.310 -.001 -1.883 -1.680 -1.880
(4.64) (29.78) (.14) (14.78) (10.41) (44.43)
Sum obese 3.208 .974 -.047 -.005
(129.35) (445.09) (1.17) (1.50)
Sum smoking -.081 -.132 -.017 3.663 3.656
(2.72) (4.09) (.86) (106.95) (106.18)
Marginal effect of sum Smoking 
(e) -.011
(2.72)
Person-year  observations 42107 42107 108817 42335 42335 109796
Level equations 




Table 4:  Relationship between Smoking and Obesity/BMI 
Notes:  




1 , 1 Pr
j j t i j j j t i j it Smoke Obese Obese    and the second one is 
an ordinary least square regression where the dependent variable is BMI:  




1 ,  . 
(b)  In this specification we estimate:  it t i t i it Smoke Smoke BMI        1 , 2 , 1 . 




1 ,   1 Pr
j j t i j j j t i j it Smoke Obese Smoke   .    We  also  estimate  a 
model in which BMI is used instead of obesity. 
(d) In this case the specification is      1 , 2 1 , 1   1 Pr       t i t i it Smoke Obese Smoke    
(e) Calculated as the sum of the individual marginal effects.  Absolute value of Z-statistics in parentheses.   26 
 
 







































Figure 1: Average BMI by Age for People who Died before 80 and All People
BMI for people who 
died before turning 
80 years old
BMI for All 
people in the 


















































































































































































































Figure 2: BMI at Previous Periods before Death by Obesity and Illness  28 




   With interactions between obesity and diseases 
    One lag    Two lags    Four lags 
   Coeff.  |t|     Coeff.  |t|     Coeff.  |t|     Coeff.  |t| 
Age  .051  (34.12)    .043  (62.93)    .047  (52.57)    .051  (34.14) 
Obese t-1  -.302  (5.48)    -.115  (2.76)    -.199  (2.74)    -.310  (2.47) 
Obese t-2  .092  (1.50)          .083  (1.31)    .097  (.75) 
Obese t-3  .065  (1.04)                .105  (.85) 
Obese t-4  .028  (.50)                -.004  (.04) 
High blood pressure t-1  -.151  (2.64)    -.003  (.23)    -.080  (2.15)    -.152  (2.59) 
High blood pressure t-2  .019  (.25)          .072  (1.94)    -.007  (.09) 
High blood pressure t-3  -.025  (.30)                -.029  (.33) 
High blood pressure t-4  .115  (1.77)                .138  (2.00) 
Diabetes t-1  .055  (.71)    .288  (15.01)    .164  (3.32)    .078  (.94) 
Diabetes t-2  -.125  (1.07)          .135  (2.57)    -.101  (.82) 
Diabetes t-3  .127  (1.03)                .055  (.41) 
Diabetes t-4  .251  (2.71)                .273  (2.70) 
Cancer t-1  .621  (10.97)    .312  (17.11)    .669  (17.52)    .643  (10.82) 
Cancer t-2  -.265  (3.00)          -.483  (11.25)    -.284  (3.09) 
Cancer t-3  -.082  (.80)                -.063  (.60) 
Cancer t-4  -.111  (1.32)                -.137  (1.55) 
Lung t-1  .238  (3.22)    .369  (18.04)    .395  (8.58)    .253  (3.26) 
Lung t-2  .090  (.86)          -.035  (.69)    .116  (1.06) 
Lung t-3  -.066  (.55)                -.064  (.51) 
Lung t-4  -.058  (.57)                -.026  (.24) 
Heart t-1  .086  (1.56)    .210  (13.23)    .171  (5.06)    .080  (1.41) 
Heart t-2  .084  (1.16)          .030  (.86)    .030  (.39) 
Heart t-3  -.017  (.23)                -.005  (.06) 
Heart t-4  .047  (.77)                .071  (1.08) 
Stroke t-1  .283  (3.79)    .417  (19.11)    .392  (8.47)    .328  (4.28) 
Stroke t-2  .202  (1.92)          .019  (.37)    .206  (1.92) 
Stroke t-3  -.060  (.50)                -.130  (1.03) 
Stroke t-4  -.077  (.73)                -.049  (.43) 
Psychiatric problems t-1  .129  (1.96)    .120  (6.00)    .222  (5.40)    .108  (1.59) 
Psychiatric problems t-2  .156  (1.70)          -.066  (1.43)    .148  (1.56) 
Psychiatric problems t-3  .085  (.84)                .095  (.91) 
Psychiatric problems t-4  -.217  (2.56)                -.188  (2.09) 
Arthritis t-1  .084  (1.59)    -.077  (5.15)    .006  (.20)    .073  (1.32) 
Arthritis t-2  -.201  (2.91)          -.131  (4.50)    -.158  (2.23) 
Arthritis t-3  .085  (1.33)                .090  (1.36) 
Arthritis t-4  -.086  (1.93)                -.115  (2.45) 
Smoking t-1  .043  (.59)    .297  (14.59)    .041  (.94)    .038  (.51) 
Smoking t-2  -.036  (.45)          .302  (7.28)    -.025  (.30) 
Smoking t-3  .156  (1.95)                .189  (2.25) 
Smoking t-4  .275  (4.13)                .243  (3.46) 
Obesity x High blood pressure (t-1)        .041  (1.04)    .009  (.13)    .024  (.22) 
Obesity x High blood pressure (t-2)              .006  (.10)    .141  (1.18)   29 
Obesity x High blood pressure (t-3)                    -.014  (.12) 
Obesity x High blood pressure (t-4)                    -.092  (.90) 
Obesity x Diabetes (t-1)        -.020  (.53)    .028  (.44)    -.070  (.66) 
Obesity x Diabetes (t-2)              -.076  (1.21)    -.078  (.63) 
Obesity x Diabetes (t-3)                    .213  (1.64) 
Obesity x Diabetes (t-4)                    -.071  (.60) 
Obesity x Cancer (t-1)        -.086  (1.88)    -.175  (2.40)    -.112  (1.00) 
Obesity x Cancer (t-2)              .093  (1.21)    .174  (1.27) 
Obesity x Cancer (t-3)                    -.242  (1.51) 
Obesity x Cancer (t-4)                    .193  (1.26) 
Obesity x Lung (t-1)        -.125  (2.59)    -.055  (.70)    -.069  (.52) 
Obesity x Lung (t-2)              -.067  (.80)    -.150  (.92) 
Obesity x Lung (t-3)                    -.006  (.03) 
Obesity x Lung (t-4)                    -.148  (.85) 
Obesity x Heart (t-1)        .091  (2.42)    .155  (2.60)    .007  (.07) 
Obesity x Heart (t-2)              .018  (.31)    .300  (2.66) 
Obesity x Heart (t-3)                    -.068  (.59) 
Obesity x Heart (t-4)                    -.095  (.89) 
Obesity x Stroke (t-1)        -.165  (3.00)    -.202  (2.36)    -.359  (2.42) 
Obesity x Stroke (t-2)              .007  (.08)    -.038  (.22) 
Obesity x Stroke (t-3)                    .387  (2.06) 
Obesity x Stroke (t-4)                    -.080  (.43) 
Obesity x Psychiatric problems (t-1)        -.035  (.77)    -.125  (1.70)    .143  (1.18) 
Obesity x Psychiatric problems (t-2)              .077  (1.03)    .033  (.23) 
Obesity x Psychiatric problems (t-3)                    -.069  (.44) 
Obesity x Psychiatric problems (t-4)                    -.121  (.82) 
Obesity x Arthritis (t-1)        -.038  (1.00)    -.025  (.40)    .077  (.72) 
Obesity x Arthritis (t-2)              .032  (.57)    -.291  (2.55) 
Obesity x Arthritis (t-3)                    -.057  (.50) 
Obesity x Arthritis (t-4)                    .210  (2.22) 
Obesity x Smoking (t-1)        .002  (.04)    -.039  (.44)    .041  (.27) 
Obesity x Smoking (t-2)              -.038  (.47)    -.082  (.51) 
Obesity x Smoking (t-3)                    -.205  (1.34) 
Obesity x Smoking (t-4)                    .195  (1.50) 
Constant  -5.649  (48.88)    -4.951  (94.61)    -5.258  (76.33)    -5.683  (48.61) 
                       
Sum of interaction by disease                       
High blood pressure        .041  (1.04)    .015  (.27)    .058  (.61) 
Diabetes        -.020  (.53)    -.049  (.92)    -.006  (.06) 
Cancer        -.086  (1.88)    -.082  (1.28)    .014  (.12) 
Lung        -.125  (2.59)    -.122  (1.80)    -.373  (2.61) 
Heart        .091  (2.42)    .173  (3.40)    .143  (1.52) 
Stroke        -.165  (3.00)    -.195  (2.50)    -.090  (.60) 
Psychiatric problems        -.035  (.77)    -.048  (.77)    -.015  (.13) 
Arthritis        -.038  (1.00)    .007  (.14)    -.061  (.64) 
Smoking        .002  (.04)    -.078  (1.02)    -.051  (.39) 
Person-year observations  36817     124410     81864     36817 
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Top Panel:  The data for this graph come from running the following model: 
        obese age e Expenditur Health 2 1 0    independently for each year of the survey.  The graph 
shows the coefficient on the obesity dummy variable (
2  ).  Gray lines represent 95 percent level 
confidence intervals. 
Bottom Panel: The information comes from running the Probit model: 
    Obese age Period Next Death 2 1 0   1     Pr         , independently for each year. The graph shows 
the change in probability of death from becoming non-obese in that model: 
      age age Period Next Death 1 0 2 1 0 ˆ ˆ   ˆ ˆ ˆ   1     Pr               . 
Source: Authors calculations based on RAND-HRS Version H. Absolute value of Z-statistics in 
parentheses.   31 
Table A1: Relationship between Smoking and Obesity/BMI  





BMI       
(OLS)
BMI         
(OLS)
Using obese as 
regressor 
(c)
Using BMI as 
regressor 
(c)
Using BMI as 
regressor 
(d)
Obese t-1 1.490 -.043
(56.27) (.76)
Obese t-2 .751 -.073
(24.86) (1.13)
Obese t-3 .483 -.050
(15.13) (.76)
Obese t-4 .470 .098
(15.73) (1.65)
BMI t-1 .618 -.022 -.011
(110.46) (3.07) (7.04)
BMI t-2 .193 -.008
(28.78) (.94)
BMI t-3 .093 .004
(13.64) (.49)
BMI t-4 .071 .019
(12.17) (2.51)
Smoking t-1 -.291 -.379 -.424 1.743 1.727 3.078
(5.58) (6.27) (12.00) (45.48) (44.84) (201.93)
Smoking t-2 .061 .106 .423 .828 .824
(1.05) (1.57) (12.43) (18.23) (18.06)
Smoking t-3 .110 .013 .513 .519
(1.88) (.19) (10.44) (10.52)
Smoking t-4 .026 .140 .553 .559
(.51) (2.50) (11.88) (11.97)
Age -.020 -.035 -.011 -.012
(17.01) (29.30) (5.91) (6.51)
Initial wealth .000 .000 .000 .000 .000 .000
(.60) (1.61) (.24) (1.94) (1.94) (4.64)
White -.084 (.08) (.04) (.00) (.00) -(.03)
(3.33) (2.69) (2.07) (.11) (.11) (1.65)
Hispanic -.016 (.03) (.11) -(.04) -(.03) -(.05)
(.44) (.69) (4.16) (.66) (.59) (1.57)
Female .012 (.07) (.05) -(.05) -(.05) -(.07)
(.55) (3.01) (2.97) (1.46) (1.50) (4.00)
Years of education -.007 (.00) (.02) -(.01) -(.01) -(.01)
(2.16) (.60) (9.44) (2.40) (2.40) (3.03)
Initial income .000 (.00) (.00) (.00) (.00) (.00)
(1.46) (.62) (5.29) (1.45) (1.41) (.70)
Initial experience .001 (.00) (.00) (.00) (.00) (.00)
(1.36) (2.58) (.71) (1.73) (1.64) (4.34)
Initial total medical expenditure .000 (.00) (.00) (.00) (.00) (.00)
(1.50) (1.38) (.89) (.67) (.75) (.15)
Constant -.247 2.997 -.343 -1.483 -1.241 -1.580
(2.51) (22.52) (9.64) (9.81) (6.70) (26.33)
Sum obese/BMI coeffs. 3.944 1.169 -.142 -.014
(93.88) (162.89) (1.78) (1.56)
Sum smoking coeffs. -.032 -.013 -.001 4.466 4.453
(.47) (.17) (.04) (73.61) (73.00)
Marginal effect of sum Smoking 
(e) -.014
(.47)




(a)  32 
Table A2: Probability of Dying at Time t  Given Obesity and Disease in Previous Periods  
(Controlling for economic determinants) 
  
No interactions 
   With interactions between obesity and diseases 
    One lag    Two lags    Four lags 
   Coeff.  |t|     Coeff.  |t|     Coeff.  |t|     Coeff.  |t| 
Age  .050  (31.54)    .042  (59.04)    .046  (49.26)    .050  (31.53) 
Obese t-1  -.304  (5.53)    -.119  (2.87)    -.200  (2.75)    -.313  (2.50) 
Obese t-2  .095  (1.57)          .056  (.89)    .138  (1.08) 
Obese t-3  .046  (.73)                .065  (.53) 
Obese t-4  .015  (.27)                -.036  (.35) 
High blood pressure t-1  -.161  (2.81)    -.013  (.82)    -.075  (2.01)    -.162  (2.74) 
High blood pressure t-2  .032  (.42)          .058  (1.56)    .010  (.13) 
High blood pressure t-3  -.026  (.31)                -.030  (.34) 
High blood pressure t-4  .108  (1.65)                .129  (1.87) 
Diabetes t-1  .037  (.46)    .253  (13.03)    .140  (2.83)    .060  (.71) 
Diabetes t-2  -.126  (1.08)          .124  (2.34)    -.108  (.88) 
Diabetes t-3  .120  (.97)                .052  (.40) 
Diabetes t-4  .241  (2.60)                .257  (2.54) 
Cancer t-1  .615  (10.77)    .343  (18.58)    .671  (17.41)    .641  (10.69) 
Cancer t-2  -.262  (2.95)          -.459  (10.62)    -.282  (3.03) 
Cancer t-3  -.079  (.77)                -.062  (.58) 
Cancer t-4  -.085  (1.00)                -.112  (1.26) 
Lung t-1  .239  (3.21)    .350  (16.93)    .387  (8.36)    .250  (3.21) 
Lung t-2  .077  (.73)          -.049  (.96)    .105  (.96) 
Lung t-3  -.062  (.52)                -.064  (.51) 
Lung t-4  -.073  (.72)                -.042  (.38) 
Heart t-1  .075  (1.36)    .199  (12.35)    .157  (4.63)    .070  (1.23) 
Heart t-2  .087  (1.18)          .035  (.98)    .033  (.43) 
Heart t-3  -.015  (.20)                -.002  (.02) 
Heart t-4  .043  (.70)                .065  (.99) 
Stroke t-1  .272  (3.65)    .389  (17.70)    .380  (8.18)    .316  (4.12) 
Stroke t-2  .197  (1.88)          .011  (.21)    .208  (1.93) 
Stroke t-3  -.063  (.53)                -.130  (1.03) 
Stroke t-4  -.083  (.79)                -.057  (.51) 
Psychiatric problems t-1  .141  (2.14)    .112  (5.52)    .220  (5.31)    .117  (1.72) 
Psychiatric problems t-2  .142  (1.55)          -.063  (1.37)    .138  (1.46) 
Psychiatric problems t-3  .075  (.74)                .082  (.78) 
Psychiatric problems t-4  -.196  (2.31)                -.166  (1.83) 
Arthritis t-1  .095  (1.77)    -.065  (4.30)    .003  (.10)    .083  (1.49) 
Arthritis t-2  -.206  (2.97)          -.121  (4.15)    -.161  (2.26) 
Arthritis t-3  .081  (1.25)                .083  (1.23) 
Arthritis t-4  -.083  (1.87)                -.116  (2.45) 
Smoking t-1  .031  (.43)    .246  (11.98)    .026  (.61)    .027  (.36) 
Smoking t-2  -.033  (.41)          .270  (6.48)    -.022  (.26) 
Smoking t-3  .153  (1.90)                .186  (2.20) 
Smoking t-4  .238  (3.57)                .205  (2.90) 
Initial wealth  .000  (5.41)    .000  (5.83)    .000  (5.00)    .000  (5.36) 
White  -.042  (1.16)    -.108  (6.08)    -.099  (4.45)    -.044  (1.19)   33 
Hispanic  -.080  (1.44)    -.149  (5.25)    -.146  (4.10)    -.087  (1.55) 
Female  -.209  (6.77)    -.277  (17.69)    -.254  (13.10)    -.203  (6.55) 
Years of education  -.006  (1.30)    -.012  (5.57)    -.012  (4.36)    -.006  (1.39) 
Initial income  .000  (2.54)    .000  (3.70)    .000  (3.25)    .000  (2.54) 
Initial experience  -.001  (1.42)    -.008  (16.33)    -.005  (9.20)    -.001  (1.28) 
Obesity x High blood pressure (t-1)        .030  (.74)    .004  (.06)    .018  (.16) 
Obesity x High blood pressure (t-2)              .015  (.24)    .111  (.94) 
Obesity x High blood pressure (t-3)                    -.009  (.07) 
Obesity x High blood pressure (t-4)                    -.087  (.85) 
Obesity x Diabetes (t-1)        -.012  (.31)    .031  (.50)    -.057  (.53) 
Obesity x Diabetes (t-2)              -.073  (1.16)    -.063  (.51) 
Obesity x Diabetes (t-3)                    .204  (1.57) 
Obesity x Diabetes (t-4)                    -.061  (.52) 
Obesity x Cancer (t-1)        -.083  (1.82)    -.184  (2.51)    -.145  (1.29) 
Obesity x Cancer (t-2)              .087  (1.12)    .174  (1.26) 
Obesity x Cancer (t-3)                    -.235  (1.46) 
Obesity x Cancer (t-4)                    .207  (1.34) 
Obesity x Lung (t-1)        -.105  (2.17)    -.050  (.64)    -.060  (.45) 
Obesity x Lung (t-2)              -.040  (.48)    -.148  (.90) 
Obesity x Lung (t-3)                    .009  (.05) 
Obesity x Lung (t-4)                    -.151  (.86) 
Obesity x Heart (t-1)        .086  (2.28)    .148  (2.48)    .002  (.02) 
Obesity x Heart (t-2)              .018  (.30)    .293  (2.59) 
Obesity x Heart (t-3)                    -.070  (.61) 
Obesity x Heart (t-4)                    -.087  (.80) 
Obesity x Stroke (t-1)        -.174  (3.16)    -.194  (2.26)    -.352  (2.37) 
Obesity x Stroke (t-2)              -.026  (.29)    -.083  (.48) 
Obesity x Stroke (t-3)                    .395  (2.10) 
Obesity x Stroke (t-4)                    -.080  (.43) 
Obesity x Psychiatric problems (t-1)        -.038  (.83)    -.125  (1.69)    .157  (1.30) 
Obesity x Psychiatric problems (t-2)              .070  (.93)    .016  (.11) 
Obesity x Psychiatric problems (t-3)                    -.060  (.38) 
Obesity x Psychiatric problems (t-4)                    -.131  (.87) 
Obesity x Arthritis (t-1)        -.041  (1.07)    -.022  (.36)    .082  (.76) 
Obesity x Arthritis (t-2)              .040  (.70)    -.306  (2.67) 
Obesity x Arthritis (t-3)                    -.035  (.30) 
Obesity x Arthritis (t-4)                    .227  (2.39) 
Obesity x Smoking (t-1)        .007  (.14)    -.033  (.37)    .034  (.22) 
Obesity x Smoking (t-2)              -.038  (.47)    -.086  (.54) 
Obesity x Smoking (t-3)                    -.195  (1.27) 
Obesity x Smoking (t-4)                    .197  (1.52) 
Constant  -5.188  (36.20)    -4.207  (65.98)    -4.594  (54.63)    -5.214  (36.04) 
                       
Sum of interaction by disease                       
High blood pressure        .030  (.74)    .019  (.34)    .033  (.35) 
Diabetes        -.012  (.31)    -.042  (.79)    .023  (.24) 
Cancer        -.083  (1.82)    -.097  (1.50)    .001  (.01) 
Lung        -.105  (2.17) 
  -.090  (1.33) 
  -.350  (2.43)   34 
Heart        .086  (2.28)    .165  (3.24)    .139  (1.47) 
Stroke        -.174  (3.16)    -.221  (2.81)    -.119  (.78) 
Psychiatric problems        -.038  (.83)    -.055  (.87)    -.018  (.15) 
Arthritis        -.041  (1.07)    .017  (.32)    -.032  (.34) 
Smoking        .007  (.14)    -.071  (.93)    -.050  (.37) 
Person-year observations  37169     128199     83491     37169 
 